Phytoceuticals Cocktail as a Potent Inhibitor of Breast Cancer Angiogenesis: In Vivo Evaluation Utilising the Chick Embryo CAM Model
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
The development of tumour vascularisation is crucial for the development and metastasis of cancer cells, primarily through the process of angiogenesis. Anti-angiogenic strategies, which inhibit the formation of new blood vessels, are promising approaches in cancer therapy. Herbal-based phytoceutical cocktail have shown to be a good source if anti-cancer bioactive compounds. This study investigates the capability of Vedicinals ® 9 Advanced to prevent and reduce breast cancer tumour angiogenesis. Vedicinals ® 9 Advanced is a polyherbal formulation containing nine medicinal plant-derived compounds. Advancing on our previous in vitro studies demonstrating its potent anti-cancer efficacy against lung cancer, this research explores the in vivo effects of Vedicinals®9 Advanced tumour angiogenesis using the chick embryo chorioallantois membrane (CAM) model. MCF7 human breast cancer cells were xenografted onto the CAM to simulate a tumour microenvironment, and Vedicinals ®9 Advanced was applied to assess its impact on tumour angiogenesis. Quantitative analysis of angiogenic parameters such as vessel area, total length, thickness, and the number of branching nodes, revealed a significant decrease in angiogenesis in breast-cancer cell environment following Vedicinals ®9 Advanced treatment. Additionally, treatment of the CAM with Vedicinals ®9 Advanced resulted in a substantial reduction of the mRNA expression of pro-angiogenic factors Vascular endothelial growth factor A (VEGFA) and Angiopoietin 1 (ANG1). These findings suggest that Vedicinals ®9 Advanced is a potent inhibitor of tumour angiogenesis, thereby reducing cancer cell metastasis and preventing further tumour development.
